Tranexamic Acid
- Product NDC
- 62559-265
- 11-digit product format
- 625590265
- Labeler code
- 62559
- Product ID
- 62559-265_edec7ff1-1b0a-414b-a719-e65376c7034b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tranexamic Acid
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- ANI Pharmaceuticals, Inc.
- Application
- ANDA203256
- Marketing category
- ANDA
- Marketing start
- 2021-07-01
- Substance
- TRANEXAMIC ACID
- Active strength
- 650 mg/1
- Pharmacologic classes
- Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tranexamic Acid
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TRANEXAMIC ACID | 650 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6T84R30KC1 |
| Rxcui | 883826 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62559-265-30 | Tranexamic Acid | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62559-265 | TRANEXAMIC ACID TABLET [ANI PHARMACEUTICALS, INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240424_82bc4879-bcf5-47c4-8636-a73c4e7d0de9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62559-265-30 | 62559026530 | 30 TABLET in 1 BOTTLE (62559-265-30) | 30 tablet | 2021-07-01 | 0000-00-00 | No | No | Current |